Literature DB >> 21641600

Improved enantiomer resolution and quantification of free D-amino acids in serum and urine by comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry.

Magdalena C Waldhier1, Martin F Almstetter, Nadine Nürnberger, Michael A Gruber, Katja Dettmer, Peter J Oefner.   

Abstract

The potential of comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry (GC×GC-TOFMS) in the quantitative analysis of amino acid enantiomers (AAEs) as their methyl chloroformate (MCF) derivatives in physiological fluids was investigated. Of the two column sets tested, the combination of an Rt-γDEXsa chiral column with a polar ZB-AAA column provided superior selectivity. Twenty AAEs were baseline resolved including L-Leu and D-Ile, which had failed separation by one-dimensional chiral GC-quadrupole-MS (GC-qMS). Lower limits of quantification (LLOQ) were in the range of 0.03-2 μM. Reproducibility of the analysis of a serum specimen in octaplicate ranged from 1.3 to 16.6%. The GC×GC-TOFMS method was validated by analyzing AAEs in 48 urine and 43 serum specimens, respectively, and by comparing the results with data obtained by a previously validated GC-qMS method. Mean recoveries ranged from 78.4% for D-Leu to 116.4% for D-Pro in urine and 72.2% for L-Thr to 129.4% for L-Ile in serum. The method was applied to the comparison of AAE serum levels in patients suffering from liver cirrhosis to a control group. Significantly increased D-AA concentrations were found for the patient group, whereas L-AA levels were slightly decreased.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21641600     DOI: 10.1016/j.chroma.2011.05.039

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  7 in total

Review 1.  Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  Metabolites       Date:  2020-01-28

2.  Chiroptical-responsive nanoprobe for the optosensing of chiral amino acids.

Authors:  Yuan Zhao; Xinyue Yuan; Wei Jiang; Huilin Liu; Baoguo Sun
Journal:  Mikrochim Acta       Date:  2022-04-08       Impact factor: 5.833

Review 3.  The metabolomic window into hepatobiliary disease.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  J Hepatol       Date:  2013-05-25       Impact factor: 25.083

4.  The human urine metabolome.

Authors:  Souhaila Bouatra; Farid Aziat; Rupasri Mandal; An Chi Guo; Michael R Wilson; Craig Knox; Trent C Bjorndahl; Ramanarayan Krishnamurthy; Fozia Saleem; Philip Liu; Zerihun T Dame; Jenna Poelzer; Jessica Huynh; Faizath S Yallou; Nick Psychogios; Edison Dong; Ralf Bogumil; Cornelia Roehring; David S Wishart
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

5.  Separation technique for the determination of highly polar metabolites in biological samples.

Authors:  Yusuke Iwasaki; Takahiro Sawada; Kentaro Hatayama; Akihito Ohyagi; Yuri Tsukuda; Kyohei Namekawa; Rie Ito; Koichi Saito; Hiroyuki Nakazawa
Journal:  Metabolites       Date:  2012-08-16

6.  Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum 1H-NMR Spectroscopy.

Authors:  Nieves Embade; Zoe Mariño; Tammo Diercks; Ainara Cano; Sabela Lens; Diana Cabrera; Miquel Navasa; Juan M Falcón-Pérez; Joan Caballería; Azucena Castro; Jaume Bosch; José M Mato; Oscar Millet
Journal:  PLoS One       Date:  2016-05-09       Impact factor: 3.240

Review 7.  Recent Advances of Microbiome-Associated Metabolomics Profiling in Liver Disease: Principles, Mechanisms, and Applications.

Authors:  Ganesan Raja; Haripriya Gupta; Yoseph Asmelash Gebru; Gi Soo Youn; Ye Rin Choi; Hyeong Seop Kim; Sang Jun Yoon; Dong Joon Kim; Tae-Jin Kim; Ki Tae Suk
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.